Diverse tumorigenic pathways in ovarian serous carcinoma

被引:294
作者
Singer, G
Kurman, RJ
Chang, HW
Cho, SKR
Shih, IM
机构
[1] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA
[2] Johns Hopkins Univ, Sch Med, Dept Gynecol & Obstet, Baltimore, MD 21205 USA
关键词
D O I
10.1016/S0002-9440(10)62549-7
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
This study was undertaken to analyze genetic alterations in 108 sporadic serous ovarian neoplasms to elucidate ovarian serous carcinogenesis. Our results demonstrate that K-ras mutations occur in approximately 50% of serous borderline tumors (SBTs), non-invasive micropapillary serous carcinomas (MPSCs), and invasive micropapillary serous carcinomas, which represent a morphological continuum of tu mor progression. Moreover, progressive increase in the degree of allelic imbalance of chromosomes 1p, 5q, 8p, 18q, 22q, and Xp was observed comparing serous borderline tumors to noninvasive and invasive micropapillary serous carcinomas. In contrast, high-grade (conventional serous carcinoma) tumors contained wild-type K-ras in all 23 cases studied and a high frequency of allelic imbalance even in small (early) primary tumors similar to that found in advanced stage tumors. Based on these findings, we propose a dualistic model for ovarian serous carcinogenesis. One pathway involves a stepwise progression from SBT to noninvasive and then invasive MPSC. The other pathway is characterized by rapid progression from the ovarian surface epithelium or inclusion cysts to a conventional (high-grade) serous carcinoma.
引用
收藏
页码:1223 / 1228
页数:6
相关论文
共 23 条
[1]  
Auersperg N, 1998, SEMIN ONCOL, V25, P281
[2]  
BELL DA, 1994, CANCER, V73, P1859, DOI 10.1002/1097-0142(19940401)73:7<1859::AID-CNCR2820730714>3.0.CO
[3]  
2-L
[4]   Micropapillary serous carcinoma of the ovary - A distinctive low-grade carcinoma related to serous borderline tumors [J].
Burks, RT ;
Sherman, ME ;
Kurman, RJ .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1996, 20 (11) :1319-1330
[5]   Comparison of mutations of Ki-RAS and p53 immunoreactivity in borderline and malignant epithelial ovarian tumors [J].
Caduff, RF ;
Svoboda-Newman, SM ;
Ferguson, AW ;
Johnston, CN ;
Frank, TS .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1999, 23 (03) :323-328
[6]  
CLIBY W, 1993, CANCER RES, V53, P2393
[7]  
DODSON MK, 1993, CANCER RES, V53, P4456
[8]  
DUBEAU L, 2001, METABOLIC MOL BASES, P1091
[9]   KI67 ANTIGEN IMMUNOSTAINING (MIB-1 MONOCLONAL-ANTIBODY) IN SEROUS OVARIAN-TUMORS - INDEX OF PROLIFERATIVE ACTIVITY WITH PROGNOSTIC-SIGNIFICANCE [J].
GARZETTI, GG ;
CIAVATTINI, A ;
GOTERI, G ;
DENICTOLIS, M ;
STRAMAZZOTTI, D ;
LUCARINI, G ;
BIAGINI, G .
GYNECOLOGIC ONCOLOGY, 1995, 56 (02) :169-174
[10]  
IWABUCHI H, 1995, CANCER RES, V55, P6172